Skip to main content

Buruli Ulcer

  • Chapter
  • First Online:
Uncommon Ulcers of the Extremities

Abstract

Buruli ulcer (BU), caused by Mycobacterium ulcerans, is a necrotizing cutaneous infection, causing a chronic debilitating disease that affects mainly the skin and sometimes bone.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Walsh DS, Portaels F, Meyers WM. Buruli ulcer: advances in understanding mycobacterium ulcerans infection. Dermatol Clin. 2011;29(1):1–8. https://doi.org/10.1016/j.det.2010.09.006.

    Article  CAS  PubMed  Google Scholar 

  2. Kumar S, Basu S, Bhartiya SK, Shukla VK. The Buruli ulcer. Int J Low Extrem Wounds. 2015;14(3):217–23.

    Article  CAS  PubMed  Google Scholar 

  3. Franco-Paredes C, Marcos LA, Henao-Martínez AF, Rodríguez-Morales AJ, Villamil-Gómez WE, Gotuzzo E, et al. Cutaneous mycobacterial infections. Clin Microbiol Rev. 2019;32(1):1–25.

    Google Scholar 

  4. Parson W. Mycobacterium ulcerans. Lancet. 2011;354(9196):2171.

    Article  Google Scholar 

  5. Manry J. Human genetics of Buruli ulcer. Hum Genet. 2020;139(6–7):847–53. https://doi.org/10.1007/s00439-020-02163-1.

    Article  PubMed  Google Scholar 

  6. Yotsu RR, Richardson M, Ishii N. Drugs for treating Buruli ulcer (Mycobacterium ulcerans disease). Cochrane Database Syst Rev. 2018;2018(8):1.

    Google Scholar 

  7. Al Ramahi JW, Annab H, Al Karmi M, Kirresh B, Wreikat M, Batarseh R, et al. Chronic cutaneous mycobacterial ulcers due to mycobacterium ulcerans (Buruli ulcer): the first indigenous case report from Jordan and a literature review. Int J Infect Dis. 2016;2017(58):77–81.

    Google Scholar 

  8. Chauty A, Ardant MF, Adeye A, Euverte H, Guédénon A, Johnson C, et al. Promising clinical efficacy of streptomycin-rifampin combination for treatment of Buruli ulcer (mycobacterium ulcerans disease). Antimicrob Agents Chemother. 2007;51(11):4029–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Almeida DV, Converse PJ, Omansen TF, Tyagi S, Tasneen R, Kim J, et al. Telacebec for ultrashort treatment of Buruli ulcer in a mouse model. Antimicrob Agents Chemother. 2020;64(6):1–10.

    Article  Google Scholar 

  10. Thomas SS, Kalia NP, Ruf MT, Pluschke G, Pethe K. Toward a single-dose cure for Buruli ulcer. Antimicrob Agents Chemother. 2020;64(9):10.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Lozano-Platonoff, A., Alonso-León, T. (2023). Buruli Ulcer. In: Khanna, A.K., Tiwary, S.K. (eds) Uncommon Ulcers of the Extremities. Springer, Singapore. https://doi.org/10.1007/978-981-99-1782-2_10

Download citation

  • DOI: https://doi.org/10.1007/978-981-99-1782-2_10

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-99-1781-5

  • Online ISBN: 978-981-99-1782-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics